Background Four studies published since December, 1995, reported that the incidence of
venous thromboembolism (VTE) was higher in women who used oral contraceptives (OCs) …

Objective: To compare the risk of idiopathic venous thromboembolism among women taking
third generation oral contraceptives (with gestodene or desogestrel) with that among women …

Aims In October 1995 in response to the results of three studies, the Committee on the
Safety of Medicines advised doctors and pharmacists that oral contraceptives containing …

Background Two recent studies, a cohort study from Denmark, and a case-control study from
The Netherlands, have reported increased risks of venous thromboembolism (VTE) among …

A matched case-control study was undertaken in 10 centers in Germany and the United
Kingdom to explore the association of current use of major combination oral contraceptives …

Objective To assess the risk of venous thromboembolism from use of combined oral
contraceptives according to progestogen type and oestrogen dose. Design National …

The objective of this study was to assess the influence of oral contraceptives (OCs) on the
risk of venous thromboembolism (VTE) in young women. A 5-year case-control study …

Objective: To evaluate quantitatively articles that compared effects of second and third
generation oral contraceptives on risk of venous thrombosis. Design: Meta-analysis. Studies …

Objective To assess the risk of venous thrombosis in current users of different types of
hormonal contraception, focusing on regimen, oestrogen dose, type of progestogen, and …

Previous discussions have indicated that the small increases of risk of venous
thromboembolism (VTE) associated with newer combined oral contraceptives (third …